A detailed history of Jane Street Group, LLC transactions in Merus N.V. stock. As of the latest transaction made, Jane Street Group, LLC holds 16,971 shares of MRUS stock, worth $842,779. This represents 0.0% of its overall portfolio holdings.

Number of Shares
16,971
Previous 74,542 77.23%
Holding current value
$842,779
Previous $4.41 Million 80.79%
% of portfolio
0.0%
Previous 0.0%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$47.19 - $58.84 $2.72 Million - $3.39 Million
-57,571 Reduced 77.23%
16,971 $847,000
Q2 2024

Aug 14, 2024

BUY
$39.81 - $60.2 $2.46 Million - $3.72 Million
61,764 Added 483.36%
74,542 $4.41 Million
Q1 2024

May 15, 2024

SELL
$28.03 - $51.82 $18,387 - $33,993
-656 Reduced 4.88%
12,778 $575,000
Q4 2023

Feb 14, 2024

BUY
$20.06 - $28.66 $269,486 - $385,018
13,434 New
13,434 $369,000
Q2 2023

Aug 14, 2023

SELL
$18.33 - $27.18 $132,452 - $196,402
-7,226 Reduced 30.12%
16,764 $441,000
Q1 2023

May 15, 2023

BUY
$14.25 - $20.5 $341,857 - $491,795
23,990 New
23,990 $441,000
Q2 2022

Aug 16, 2022

SELL
$13.98 - $29.25 $263,802 - $551,947
-18,870 Closed
0 $0
Q1 2022

May 17, 2022

BUY
$23.58 - $30.91 $444,954 - $583,271
18,870 New
18,870 $499,000

Others Institutions Holding MRUS

About Merus N.V.


  • Ticker MRUS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,878,200
  • Market Cap $2.28B
  • Description
  • Merus N.V., a clinical-stage immuno-oncology company, engages in the discovery and development of bispecific antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes Zenocutuzumab (MCLA-128), which is in a phase 2 clinical trials for the treatment of patients with metastatic breast cancer, as well as in Phase...
More about MRUS
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.